The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature

被引:12
作者
Zhou, Sitong [1 ]
Sun, Yidan [2 ]
Chen, Tianqi [2 ]
Wang, Jingru [3 ]
He, Jia [3 ]
Lyu, Jin [4 ]
Shen, Yanna [5 ]
Chen, Xiaodong [3 ]
Yang, Ronghua [3 ]
机构
[1] First Peoples Hosp Foshan, Dept Dermatol, Foshan, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Dept Oncol, Tianjin, Peoples R China
[3] First Peoples Hosp Foshan, Dept Burn Surg & Skin Regenerat, Foshan, Peoples R China
[4] First Peoples Hosp Foshan, Dept Pathol, Foshan, Peoples R China
[5] Tianjin Med Univ, Sch Med Lab, Tianjin, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金
中国国家自然科学基金;
关键词
skin cutaneous melanoma; prognostic biomarker; tumor microenvironment; gene signature; immuno-genomic landscape; clinicopathological characteristics; EXPRESSION; SRPX2; CANCER; INVASION; PACKAGE; PATHWAY;
D O I
10.3389/fcell.2021.739594
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The tumorigenesis of skin cutaneous melanoma (SKCM) remains unclear. The tumor microenvironment (TME) is well known to play a vital role in the onset and progression of SKCM. However, the dynamic mechanisms of immune regulation are insufficient. We conducted a comprehensive analysis of immune cell infiltration in the TME. Based on the differentially expressed genes (DEGs) in clusters grouped by immune infiltration status, a set of hub genes related to the clinical prognosis of SKCM and tumor immune infiltration was explored.</p> Methods: We analyzed immune cell infiltration in two independent cohorts and assessed the relationship between the internal pattern of immune cell infiltration and SKCM characteristics, including clinicopathological features, potential biological pathways, and gene mutations. Genes related to the infiltration pattern of TME immune cells were determined. Furthermore, the unsupervised clustering method (k-means) was used to divide samples into three different categories according to TME, which were defined as TME cluster-A, -B, and -C. DEGs among three groups of samples were analyzed as signature genes. We further distinguished common DEGs between three groups of samples according to whether differences were significant and divided DEGs into the Signature gene-A group with significant differences and the Signature gene-B group with insignificant differences. The Signature gene-A gene set mainly had exon skipping in SKCM, while the Signature gene-B gene set had no obvious alternative splicing form. Subsequently, we analyzed genetic variations of the two signatures and constructed a competing endogenous RNA (ceRNA) regulatory network. LASSO Cox regression was used to determine the immune infiltration signature and risk score of SKCM. Finally, we obtained 13 hub genes and calculated the risk score based on the coefficient of each gene to explore the impact of the high- and low-risk scores on biologically related functions and prognosis of SKCM patients further. The correlation between the risk score and clinicopathological characteristics of SKCM patients indicated that a low-risk score was associated with TME cluster-A classification (p < 0.001) and metastatic SKCM (p < 0.001). Thirteen hub genes also showed different prognostic effects in pan-cancer. The results of univariate and multivariate Cox analyses revealed that risk score could be used as an independent risk factor for predicting the prognosis of SKCM patients. The nomogram that integrated clinicopathological characteristics and immune characteristics to predict survival probability was based on multivariate Cox regression. Finally, 13 hub genes that showed different prognostic effects in pan-cancers were obtained. According to immunohistochemistry staining results, Ube2L6, SRPX2, and IFIT2 were expressed at higher levels, while CLEC4E, END3, and KIR2DL4 were expressed at lower levels in 25 melanoma specimens.</p> Conclusion: We performed a comprehensive assessment of the immune-associated TME. To elucidate the potential development of immune-genomic features in SKCM, we constructed an unprecedented set of immune characteristic genes (EDN3, CLEC4E, SRPX2, KIR2DL4, UBE2L6, and IFIT2) related to the immune landscape of TME. These genes are related to different prognoses and drug responses of SKCM. The immune gene signature constructed can be used as a robust prognostic biomarker of SKCM and a predictor of an immunotherapy effect.</p>
引用
收藏
页数:17
相关论文
共 47 条
[1]   The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy? [J].
Attia, Jiji V. D. ;
Dessens, Charlotte E. ;
van de Water, Ricky ;
Houvast, Ruben D. ;
Kuppen, Peter J. K. ;
Krijgsman, Danielle .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-18
[2]   VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R [J].
Chen, Hanbo ;
Boutros, Paul C. .
BMC BIOINFORMATICS, 2011, 12
[3]   Calcineurin A gamma and NFATc3/SRPX2 axis contribute to human embryonic stem cell differentiation [J].
Chen, Hao ;
Zeng, Yanwu ;
Shao, Min ;
Zhao, Hanzhi ;
Fang, Zhuoqing ;
Gu, Junjie ;
Liao, Bing ;
Jin, Ying .
JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) :5698-5713
[4]   MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial [J].
Dreno, Brigitte ;
Thompson, John F. ;
Smithers, Bernard Mark ;
Santinami, Mario ;
Jouary, Thomas ;
Gutzmer, Ralf ;
Levchenko, Evgeny ;
Rutkowski, Piotr ;
Grob, Jean-Jacques ;
Korovin, Sergii ;
Drucis, Kamil ;
Grange, Florent ;
Machet, Laurent ;
Hersey, Peter ;
Krajsova, Ivana ;
Testori, Alessandro ;
Conry, Robert ;
Guillot, Bernard ;
Kruit, Wim H. J. ;
Demidov, Lev ;
Thompson, John A. ;
Bondarenko, Igor ;
Jaroszek, Jaroslaw ;
Puig, Susana ;
Cinat, Gabriela ;
Hauschild, Axel ;
Goeman, Jelle J. ;
van Houwelingen, Hans C. ;
Ulloa-Montoya, Fernando ;
Callegaro, Andrea ;
Dizier, Benjamin ;
Spiessens, Bart ;
Debois, Muriel ;
Brichard, Vincent G. ;
Louahed, Jamila ;
Therasse, Patrick ;
Debruyne, Channa ;
Kirkwood, John M. .
LANCET ONCOLOGY, 2018, 19 (07) :916-929
[5]   Toward a molecular classification of melanoma [J].
Fecher, Leslie A. ;
Cummings, Staci D. ;
Keefe, Megan J. ;
Alani, Rhoda M. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1606-1620
[6]   SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis [J].
Gao, Zhenyuan ;
Wu, Jisong ;
Wu, Xiao ;
Zheng, Jialei ;
Ou, Yimei .
OPEN MEDICINE, 2020, 15 (01) :1072-1082
[7]  
Gao ZY, 2015, INT J CLIN EXP PATHO, V8, P4791
[8]   Strategies for early melanoma detection: Approaches to the patient with nevi [J].
Goodson, Agnessa Gadeliya ;
Grossman, Douglas .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (05) :719-735
[9]   Toward a Shared Vision for Cancer Genomic Data [J].
Grossman, Robert L. ;
Heath, Allison P. ;
Ferretti, Vincent ;
Varmus, Harold E. ;
Lowy, Douglas R. ;
Kibbe, Warren A. ;
Staudt, Louis M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (12) :1109-1112
[10]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674